FSH replaced by low-dose hCG in the late follicular phase versus continued FSH for assisted reproductive techniques

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 3, 2013, Pages

  Martins, Wellington P ^a   Vieira, Andrea D D ^a   Figueiredo, Jaqueline B P ^a   Nastri, Carolina O ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; FERTILITY PROMOTING AGENT;

DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLICULAR PHASE; FOLLOW UP; HUMAN; INFERTILITY THERAPY; LIVE BIRTH; LOW DRUG DOSE; META ANALYSIS; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; CONFIDENCE INTERVAL; DRUG EFFECT; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ABORTION, SPONTANEOUS; CHORIONIC GONADOTROPIN; CONFIDENCE INTERVALS; DRUG SUBSTITUTION; FEMALE; FERTILITY AGENTS, FEMALE; FOLLICLE STIMULATING HORMONE; FOLLICULAR PHASE; HUMANS; LIVE BIRTH; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCTIVE TECHNIQUES, ASSISTED;

MLCS; MLOWN;

EID: 84880127977     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010042.pub2     Document Type: Review

References (39)

1. Aflatoonian A, Yousefnejad F, Eftekhar M, Mohammadian F. Efficacy of low-dose hCG in late follicular phase in controlled ovarian stimulation using GnRH agonist protocol. Archives of Gynecology and Obstetrics 2012;286(3):771-5. [PUBMED: 22619027].
2. Ashrafi M, Kiani K, Ghasemi A, Rastegar F, Nabavi M. The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical trial of efficacy and safety. Archives of Gynecology and Obstetrics 2011;284(6):1431-8. [PUBMED: 21210134].
3. Blockeel C, De Vos M, Verpoest W, Stoop D, Haentjens P, Devroey P. Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study. Human Reproduction 2009;24(11):2910-6. [PUBMED: 19617207].
4. Filicori M, Cognigni GE, Gamberini E, Parmegiani L, Troilo E, Roset B. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation. Fertility and Sterility 2005;84(2):394-401. [PUBMED: 16084880].
5. Filicori M, Cognigni GE, Parmegiani L, Taraborrelli S, Gamberini E, Bernardi S. Stimulation of folliculogenesis with low-dose human chorionic gonadotropin(hCG) alone in ovulation induction. Fertility and Sterility. 2004; Vol. 82:S3.
6. Filicori M, Cognigni GE, Parmegiani L, Taraborrelli S, Tabarelli C, Gamberini E, et al.Efficacy of low-dose hCG in ovarian stimulation. Human Reproduction. 2004; Vol. 19 Suppl 1:i119-20.
7. Gomes MK, Vieira CS, Moura MD, Manetta LA, Leite SP, Reis RM, et al. Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2007;130(1):99-106. [PUBMED: 16835006].
8. Beretsos P, Partsinevelos GA, Arabatzi E, Drakakis P, Mavrogianni D, Anagnostou E, et al. "hCG priming" effect in controlled ovarian stimulation through a long protocol. Reproductive Biology and Endocrinology 2009;31(7):91. [PUBMED: 19719843].
9. Berkkanoglu M, Isikoglu M, Aydin D, Ozgur K. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders. Fertility and Sterility 2007;88(3):665-9. [PUBMED: 17292895].
10. Check JH, Davies E, Brasile D, Choe JK, Amui J. A prospective comparison of in vitro fertilization (IVF) outcome following controlled ovarian hyperstimulation (COH) regimens using follitropin alpha exclusively or with the addition of low dose human chorionic gonadotropin (hCG) and ganirelix. Clinical and Experimental Obstetrics & Gynecology 2009;36(4):217-8. [PUBMED: 20101851].
11. Dehghani-Firouzabady R, Asgharnia M, Tayebi N, Kalantar SM. Use of low-dose human chorionic gonadotropin (hCG) for final follicular maturation in ovulatory women treated by intrauterine insemination. Middle East Fertility Society Journal 2006;11(3):201-5.
12. Drakakis P, Loutradis D, Beloukas A, Sypsa V, Anastasiadou V, Kalofolias G, et al. Early hCG addition to rFSH for ovarian stimulation in IVF provides better results and the cDNA copies of the hCG receptor may be an indicator of successful stimulation. Reproductive Biology and Endocrinology 2009;13(7):110. [PUBMED: 19825188].
13. Filicori M, Cognigni GE, Taraborrelli S, Spettoli D, Ciampaglia W, de Fatis CT, et al. Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome. The Journal of Clinical Endocrinology and Metabolism 1999;84(8):2659-63. [PUBMED: 10443656].
14. Filicori M, Cognigni GE, Tabarelli C, Pocognoli P, Taraborrelli S, Spettoli D, Ciampaglia W. Stimulation and growth of antral ovarian follicles by selective LH activity administration in women. The Journal of Clinical Endocrinology and Metabolism 2002;87(3):1156-61. [PUBMED: 11889180].
15. Filicori M, Cognini GE, Ferlini F, Ciampaglia W, Pocognoli P, Parmegiani L, Troilo E, Bernardi S, Gamberini E. Prospective randomized, dose finding study of low-dose human chorionic gonadotropin (hCG) administration in controlled ovarian stimulation (COS). Abstracts of the 21st Annual Meeting of the ESHRE. 2005:i64-5.
16. Koichi K, Yukiko N, Shima K, Sachiko S. Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol. Journal of Assisted Reproduction and Genetics 2006;23(5):223-8. [PUBMED: 16786420].
17. Kyono K, Fuchinoue K, Nakajo Y, Yagi A, Sasaki K. A prospective randomized study of three ovulation induction protocols for IVF: GnRH agonist versus antagonist with and without low dose hCG. Fertility and Sterility. 2004; Vol. 82:s31.
18. Lossl K, Andersen CY, Loft A, Freiesleben NL, Bangsbøll S, Andersen AN. Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial. Human Reproduction 2008;23(8):1820-9. [PUBMED: 18487212].
19. Mendes IR, Kotecki JA, Caldeira G, Lazar F, Serafini PC, Motta EL. Will the administration of low-dose hCG for ovulation induction in association with bromocriptine aid in the prevention of OHSS?. Fertility and Sterility. 2005; Vol. 84:S313.
20. Serafini P, Yadid I, Motta EL, Alegretti JR, Fioravanti J, Coslovsky M. Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial. Fertility and Sterility 2006;86(4):830-8. [PUBMED: 16963040].
21. Thuesen LL, Loft A, Egeberg AN, Smitz J, Petersen JH, Nyboe Andersen A. A randomized controlled dose-response pilot study of addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization. Human Reproduction 2012;27(10):3074-84. [PUBMED: 22791754].
22. Thuesen LL, Loft A, Egeberg AN, Smitz J, Petersen JH, Nyboe Andersen A. Supplementation with hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilisation: a randomised controlled dose-finding study. Human Reproduction. 2011; Vol. 26 Suppl 1:i27-8.
23. Van Horne AK, Bates GW Jr, Robinson RD, Arthur NJ, Propst AM. Recombinant follicle-stimulating hormone (rFSH) supplemented with low-dose human chorionic gonadotropin compared with rFSH alone for ovarian stimulation for in vitro fertilization. Fertility and Sterility 2007;88(4):1010-3. [PUBMED: 17434503].
24. Aleyamma TK, Kamath MS, Muthukumar K, Mangalaraj AM, George K. Affordable ART: a different perspective. Human Reproduction 2011;26(12):3312-8. [PUBMED: 21987524].
25. Checa MA, Espinós JJ, Requena A. Efficacy and safety of human chorionic gonadotropin for follicular phase stimulation in assisted reproduction: a systematic review and meta-analysis. Fertility and Sterility 2012;97(6):1343-50. [PUBMED: 22464087].
26. Filicori M, Cognigni GE, Samara A, Melappioni S, Perri T, Cantelli B, et al.The use of LH activity to drive folliculogenesis: exploring uncharted territories in ovulation induction. Human Reproduction Update 2002;8(6):543-57. [PUBMED: 12498424].
27. Filicori M, Cognigni GE, Tabarelli C, Pocognoli P, Taraborrelli S, Spettoli D, et al.Stimulation and growth of antral ovarian follicles by selective LH activity administration in women. The Journal of Clinical Endocrinology and Metabolism 2002;87(3):1156-61. [PUBMED: 11889180].
28. Gnoth C, Maxrath B, Skonieczny T, Friol K, Godehardt E, Tigges J. Final ART success rates: a 10 years survey. Human Reproduction 2011;26(8):2239-46. [PUBMED: 21659314].
29. Higgins J, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
30. Kosmas IP, Zikopoulos K, Georgiou I, Paraskevaidis E, Blockeel C, Tournaye H, et al.Low-dose HCG may improve pregnancy rates and lower OHSS in antagonist cycles: a meta-analysis. Reproductive Biomedicine Online 2009;19(5):619-30. [PUBMED: 20021711].
31. Macklon NS, Stouffer RL, Giudice LC, Fauser BC. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocrine Reviews 2006;27(2):170-207. [PUBMED: 16434510].
32. Nastri CO, Ferriani RA, Rocha IA, Martins WP. Ovarian hyperstimulation syndrome: pathophysiology and prevention. Journal of Assisted Reproduction and Genetics 2010;27(2-3):121-8. [PUBMED: 20140640].
33. Pelinck MJ, Vogel NE, Hoek A, Simons AH, Arts EG, Mochtar MH, et al.Cumulative pregnancy rates after three cycles of minimal stimulation IVF and results according to subfertility diagnosis: a multicentre cohort study. Human Reproduction 2006;21(9):2375-83. [PUBMED: 16751647].
34. Ross GT. Clinical relevance of research on the structure of human chorionic gonadotropin. American Journal of Obstetrics and Gynecology 1977;129(7):795-808. [PUBMED: 343593].
35. Shima K, Kitayama S, Nakano R. Gonadotropin binding sites in human ovarian follicles and corpora lutea during the menstrual cycle. Obstetrics and Gynecology 1987;69(5):800-6. [PUBMED: 3106871].
36. Takao Y, Honda T, Ueda M, Hattori N, Yamada S, Maeda M, et al.Immunohistochemical localization of the LH/HCG receptor in human ovary: hCG enhances cell surface expression of LH/HCG receptor on luteinizing granulosa cells in vitro. Molecular Human Reproduction 1997;3(7):569-78. [PUBMED: 9268134].
37. Thoma ME, McLain AC, Louis JF, King RB, Trumble AC, Sundaram R, et al. Prevalence of infertility in the United States as estimated by the current duration approach and a traditional constructed approach. Fertility and Sterility 2013;in press. [PUBMED: 23290741].
38. Verberg MF, Macklon NS, Nargund G, Frydman R, Devroey P, Broekmans FJ, et al.Mild ovarian stimulation for IVF. Human Reproduction Update 2009;15(1):13-29. [PUBMED: 19091755].
39. Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R, Nygren K, et al.International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Human Reproduction 2009;24(11):2683-7. [PUBMED: 19828144].